ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 86 filers reported holding ANTARES PHARMA INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $93,000 | +38.8% | 40,000 | 0.0% | 0.03% | +50.0% |
Q3 2016 | $67,000 | -96.3% | 40,000 | -97.7% | 0.02% | -96.1% |
Q2 2016 | $1,823,000 | +20.6% | 1,736,256 | 0.0% | 0.46% | +20.6% |
Q1 2016 | $1,511,000 | -23.0% | 1,736,256 | +7.0% | 0.38% | -19.5% |
Q4 2015 | $1,963,000 | -29.9% | 1,622,949 | -1.5% | 0.47% | -40.5% |
Q3 2015 | $2,801,000 | -12.2% | 1,647,592 | +7.4% | 0.79% | -10.9% |
Q2 2015 | $3,191,000 | -23.6% | 1,534,283 | -0.5% | 0.89% | -19.0% |
Q1 2015 | $4,178,000 | -22.1% | 1,541,770 | -26.1% | 1.10% | -20.6% |
Q4 2014 | $5,360,000 | +28.3% | 2,085,886 | -8.7% | 1.38% | +10.7% |
Q3 2014 | $4,179,000 | -33.1% | 2,283,476 | -2.4% | 1.25% | -27.9% |
Q2 2014 | $6,244,000 | +17.9% | 2,338,735 | +54.5% | 1.73% | +13.4% |
Q1 2014 | $5,298,000 | -34.1% | 1,513,735 | -15.8% | 1.53% | -35.9% |
Q4 2013 | $8,042,000 | +8.6% | 1,798,735 | -1.4% | 2.38% | +3.1% |
Q3 2013 | $7,404,000 | +4.8% | 1,823,735 | +7.4% | 2.31% | +7.7% |
Q2 2013 | $7,067,000 | – | 1,698,735 | – | 2.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sargent Investment Group, LLC | 3,096,355 | $8,422,000 | 5.18% |
JW Asset Management, LLC | 1,920,524 | $5,224,000 | 3.85% |
Healthcare Value Capital, LLC | 250,000 | $680,000 | 2.64% |
ARMISTICE CAPITAL, LLC | 10,300,000 | $28,016,000 | 2.12% |
Broadfin Capital, LLC | 3,444,147 | $9,368,000 | 1.23% |
PERKINS CAPITAL MANAGEMENT INC | 409,000 | $1,112,000 | 0.86% |
MYCIO WEALTH PARTNERS, LLC | 1,896,500 | $5,158,000 | 0.48% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 1,012,600 | $2,754,000 | 0.22% |
FALCON POINT CAPITAL, LLC | 130,200 | $354,000 | 0.21% |
Brown Advisory Securities, LLC | 275,000 | $781,000 | 0.15% |